TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05120141

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: American Dental Association (ADA) Ref Toothbrush
Description: Participants will use soft bristled Toothbrush for brushing teeth twice daily.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: American Dental Association (ADA) Ref Toothbrush
Description: Participants will use soft bristled Toothbrush for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: American Dental Association (ADA) Ref Toothbrush
Description: Participants will use soft bristled Toothbrush for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: American Dental Association (ADA) Ref Toothbrush
Description: Participants will use soft bristled Toothbrush for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: American Dental Association (ADA) Ref Toothbrush
Description: Participants will use soft bristled Toothbrush for brushing teeth twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 1 Mouth Rinse
Description: Participants will use 20 mL of Prototype 1 Mouth Rinse for 30 seconds after brushing twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 2 Mouth Rinse
Description: Participants will use 20 mL of Prototype 2 Mouth Rinse for 30 seconds after brushing twice daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prototype 3 Mouth Rinse
Description: Participants will use 20 mL of Prototype 3 Mouth Rinse for 30 seconds after brushing twice daily.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Listerine Cool Mint Mouth Rinse
Description: Participants will use 20 mL of Listerine Cool Mint Mouth Rinse for 30 seconds after brushing twice daily.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hydroalcohol Mouth Rinse
Description: Participants will use 20 mL of Hydroalcohol Mouth Rinse for 30 seconds after brushing twice daily.
Study: NCT05009667

Intervention type: DEVICE
Intervention: Angiography-derived Index of Microcirculatory Resistance
Description: caIMR will be measured by pressure sensors which are produced by Suzhou Rainmed Medical Technology Co., Ltd.~caIMR is calculated based on angiography images and Hyperemic Pa estimated from resting Pa according to prespecified equation.

Intervention type: DEVICE
Intervention: Angiography-derived Index of Microcirculatory Resistance
Description: caIMR will be measured by pressure sensors which are produced by Suzhou Rainmed Medical Technology Co., Ltd.~caIMR is calculated based on angiography images and Hyperemic Pa estimated from resting Pa according to prespecified equation.

Intervention type: DEVICE
Intervention: Pressure wire-based Index of Microcirculatory Resistance
Description: IMR will be measured by thermodilution method with pressure wire and arterial physiological detector which are produced by St. Jude Medical.~IMR = Pd ∙Tmn

Intervention type: DEVICE
Intervention: Pressure wire-based Index of Microcirculatory Resistance
Description: IMR will be measured by thermodilution method with pressure wire and arterial physiological detector which are produced by St. Jude Medical.~IMR = Pd ∙Tmn
Study: NCT05186649

Intervention type: OTHER
Intervention: WARFARIN
Description: 5 mg of daily dosage
Study: NCT05790317

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Procedure with ERAS Protocol
Description: It covers the period before, during and after the surgery.
Study: NCT05034588

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance scan
Description: Multiparametric cardiac magnetic resonance, including functional and structural parameter

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance scan
Description: Multiparametric cardiac magnetic resonance, including functional and structural parameter
Study: NCT05208788

Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker test
Description: collection of 500µl to 1 ml of a spot urine sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker test
Description: collection of 500µl to 1 ml of a spot urine sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker test
Description: collection of 500µl to 1 ml of a spot urine sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker test
Description: collection of 500µl to 1 ml of a spot urine sample
Study: NCT05647642

Intervention type: DRUG
Intervention: Precedex and dormicum
Description: Premedication

Intervention type: DRUG
Intervention: Precedex and dormicum
Description: Premedication

Intervention type: DRUG
Intervention: Precedex and dormicum
Description: Premedication

Intervention type: DRUG
Intervention: Precedex and dormicum
Description: Premedication
Study: NCT06281951

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl - Inhalation by facial nebulization
Description: 3 administrations based on a weight-dependent threshold (40 µg per administration for a weight \< 70kg and 50 µg per administration for a weight ≥ 70kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl - Nebulisation
Description: 3 administrations based on a weight-dependent threshold (20 µg/administration and for a weight \< 70kg and 30 µg/administration for a weight ≥ 70kg). The dose of each bolus will be distributed at equivalent volume in both nasal pits
Study: NCT06620133

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain education and patient-led goal setting
Description: 8 week program delivered via five, up to 1-hour telehealth sessions. The sessions will be scheduled at approximately fortnightly intervals. Participants will also be prescribed approximately 30 minutes of online activities with each session. Pain education will be based on Explain Pain and the curriculum will have specified learning objectives adapted for each individual participant. Participants will access the online education curriculum through Pathwright. For patient-led goal setting, the healthcare practitioner will take an initial history of the participants physical activity behaviours and problems related to their back pain. The participant will prioritise their problems according to impact in their life. Strategies will then be discussed, and the participant will, in collaboration with the healthcare practitioner, set goals and strategies to work on independently between sessions.
Study: NCT05117541

Intervention type: OTHER
Intervention: Interview
Description: Participate in interviews

Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of hair samples

Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records are reviewed
Study: NCT03938207

Intervention type: DIAGNOSTIC_TEST
Intervention: Demographics, personal health behavior, living environment, dietary status, family history
Description: To investigate the difference among the demographics, personal health behavior, living environment, dietary status, family history of among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease.
Study: NCT04597840

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Incisional hernia repair with reinforcement of biosynthetic mesh
Description: The biosynthetic mesh (Phasix or Bio-A meshes) will be placed as a sublay in the retromuscular position to reinforce midline fascial closure. All the surgical procedure (including placement and fixation of the mesh) will be performed according to a standardized protocol.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Incisional hernia repair with simple suture or synthetic mesh reinforcement.
Description: Based on the discretion of the surgeon, the incisional hernia repair will be done by simple suture or by synthetic mesh reinforcement. All the surgical procedure (including placement and fixation of the mesh if applicable) will be performed according to a standardized protocol.
Study: NCT05384509

Intervention type: DIAGNOSTIC_TEST
Intervention: solid organ malignancies treatment
Description: Major inclusion criteria for this cohort of the study included: (1) age above 20 years; (2) presence of solid organ malignancies treated with immunotherapy, chemotherapy, Target therapy irrespective of the treatment phase; and (3) eligibility for vaccination.
Study: NCT06620133

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised group exercise
Description: Participants will be asked to attend 1-2 sessions of online supervised group exercise each week for 8 weeks. The sessions will be performed in small groups (up to 8 people) and be led by a trained healthcare practitioner. The prescribed exercises will be able to be performed at home with minimal equipment and will mostly involve bodyweight resistance training targeting the major muscle groups.
Study: NCT05384509

Intervention type: DIAGNOSTIC_TEST
Intervention: solid organ malignancies treatment
Description: Major inclusion criteria for this cohort of the study included: (1) age above 20 years; (2) presence of solid organ malignancies treated with immunotherapy, chemotherapy, Target therapy irrespective of the treatment phase; and (3) eligibility for vaccination.

Intervention type: DIAGNOSTIC_TEST
Intervention: solid organ malignancies treatment
Description: Major inclusion criteria for this cohort of the study included: (1) age above 20 years; (2) presence of solid organ malignancies treated with immunotherapy, chemotherapy, Target therapy irrespective of the treatment phase; and (3) eligibility for vaccination.

Intervention type: DIAGNOSTIC_TEST
Intervention: solid organ malignancies treatment
Description: Major inclusion criteria for this cohort of the study included: (1) age above 20 years; (2) presence of solid organ malignancies treated with immunotherapy, chemotherapy, Target therapy irrespective of the treatment phase; and (3) eligibility for vaccination.
Study: NCT06295757

Intervention type: OTHER
Group type: OTHER
Intervention: Cigarettes
Description: Participants will smoke their own usual brand cigarettes. Cigarette butts will be collected.

Intervention type: OTHER
Group type: OTHER
Intervention: Cigarettes
Description: Participants will smoke their own usual brand cigarettes. Cigarette butts will be collected.
Study: NCT05231291

Intervention type: OTHER
Intervention: hand grip strength
Description: Observational study
Study: NCT03938207

Intervention type: DIAGNOSTIC_TEST
Intervention: Demographics, personal health behavior, living environment, dietary status, family history
Description: To investigate the difference among the demographics, personal health behavior, living environment, dietary status, family history of among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease.

Intervention type: DIAGNOSTIC_TEST
Intervention: HLA typing
Description: Using HLA typing from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.
Study: NCT05464849

Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of systemic skin microvascular endothelial function
Description: Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.

Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of systemic skin microvascular endothelial function
Description: Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.

Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of systemic skin microvascular endothelial function
Description: Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.
Study: NCT05257902

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: choline alphoscerate
Description: 400mg bid/day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 1T bid/day
Study: NCT05095168

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAN106
Description: CAN106 is a selective inhibitor of complement activation, which binds to the complement component C5.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study: NCT03938207

Intervention type: DIAGNOSTIC_TEST
Intervention: Metabolomics
Description: Using Metabolomics from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Metabolomics
Description: Using Metabolomics from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Environmental Toxic
Description: Using Environmental Toxic from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Environmental Toxic
Description: Using Environmental Toxic from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Environmental Toxic
Description: Using Environmental Toxic from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Environmental Toxic
Description: Using Environmental Toxic from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical Image
Description: Using Medical Image from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical Image
Description: Using Medical Image from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.
Study: NCT04777422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Defibrotide
Description: Defibrotide 6.25 mg/kg IV q6h up to 7 days
Study: NCT04028752

Intervention type: BIOLOGICAL
Intervention: Blood collected specifically for this study
Description: The subject will be sitting in a chair, and a needle will be inserted into a vein in the arm. Study Team will draw about 45ml or 3 tablespoons of whole blood for research.
Study: NCT03938207

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical Image
Description: Using Medical Image from Taiwan Biobank among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease to investigate the difference among the genetic variant, gene copy number, single nucleotide variation, chromosomal recombination, and very low-level gene expression differences.
Study: NCT06095323

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg)
Description: The intervention group will wear compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg) during the day for 12 months.
Study: NCT05133518

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MELT-300
Description: Sublingual tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam alone
Description: Sublingual tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine alone
Description: Sublingual tablet

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sublingual tablet
Study: NCT04765150

Intervention type: PROCEDURE
Intervention: 3 Tesla Magnetic Resonance Imaging
Description: Undergo 3T MRI

Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical charts are reviewed
Study: NCT05533047

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TURP
Description: Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TURP
Description: Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia
Study: NCT05045144

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: RSVPreF3(120 μg)
Description: A single dose of RSVPreF3(120 μg) combined with Sodium Chloride (NaCl) was administrated intramuscular (IM). There were used 3 different lots of RSVPreF3(120 μg), one for each individual group (RSV lot1 Group, RSV lot2 Group and RSV lot3 Group) considered under RSV pooled Group.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: RSVPreF3(120 μg)
Description: A single dose of RSVPreF3(120 μg) combined with Sodium Chloride (NaCl) was administrated intramuscular (IM). There were used 3 different lots of RSVPreF3(120 μg), one for each individual group (RSV lot1 Group, RSV lot2 Group and RSV lot3 Group) considered under RSV pooled Group.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: RSVPreF3(120 μg)
Description: A single dose of RSVPreF3(120 μg) combined with Sodium Chloride (NaCl) was administrated intramuscular (IM). There were used 3 different lots of RSVPreF3(120 μg), one for each individual group (RSV lot1 Group, RSV lot2 Group and RSV lot3 Group) considered under RSV pooled Group.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Flu Quadrivalent influenza vaccine (15 μg HA)
Description: A single dose of Flu Quadrivalent influenza (15 μg HA) vaccine was administrated intramuscular (IM).

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Flu Quadrivalent influenza vaccine (15 μg HA)
Description: A single dose of Flu Quadrivalent influenza (15 μg HA) vaccine was administrated intramuscular (IM).

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: One dose of placebo, administered intramuscularly in the deltoid region of the right arm, at Day 1.
Study: NCT04049851

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxidectin 2 MG Oral Tablet
Description: One Moxidectin 2 mg tablet will be blinded and will be administrated with 3 tablets of placebo.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin 3Mg Tab
Description: 3 ivermectin tablets (or 4 according to the weight) will be blinded and will be administrated with 1 (or 0 according to the weight) tablet of placebo.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral tablet
Description: Placebo will be administrated with Moxidectin or ivermectin. Each participant will have 4 tablets in total.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral tablet
Description: Placebo will be administrated with Moxidectin or ivermectin. Each participant will have 4 tablets in total.
Study: NCT04295512

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unstuck and on Target (UOT)
Description: Unstuck and on Target (UOT) is a cognitive-behavioral treatment that directly addresses executive functioning and self-regulation deficits in ASD and ADHD. UOT is the first contextually-based executive functioning treatment that targets flexibility, goal-setting and planning through a cognitive behavioral program centered on self-regulatory scripts that are consistently modeled and reinforced. UOT will be adapted for use in mental health service settings. Mental health therapists will be trained in UOT and deliver to youth and caregivers.
Study: NCT05959876

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training group
Description: Face-to-face perineal care training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: No intervention